Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
October 28, 2020 at 05:48 am EDT
Share
Guangdong Biolight Meditech Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 1,101.511 million compared to CNY 609.088 million a year ago. Operating income was CNY 378.502 million compared to CNY 75.313 million a year ago. Net income was CNY 314.873 million compared to CNY 55.457 million a year ago. Basic earnings per share from continuing operations was CNY 2.1554 compared to CNY 0.3796 a year ago.
GUANGDONG BIOLIGHT MEDITECH CO., LTD. is a China-based company principally engaged in the research, development, production and sales of medical monitoring equipment, hemodialysis products and ancillary products. Its medical monitoring equipment includes monitoring equipment, electrocardiograph, pulse oximeters and central monitoring systems. Its hemodialysis products include hemodialysis machines, hemodialyzers, hemodialysis powders/dialysates and perfusion machines. The Company distributes its products in domestic and overseas markets.
GUANGDONG BIOLIGHT MEDITECH CO., LTD. 
